CSNK1A1 and cancer: Although targeting CK1α therapeutically would have multiple unwanted consequences, the potential to inhibit specific pools of CK1α and potentially specific substrates through inhibition of the FAM83F-CK1α complex could make FAM83F an attractive therapeutic target in cancer.